Status:
COMPLETED
Effect of Fixed vs. Tailored Intensity tDCS for Attention Deficit After TBI
Lead Sponsor:
Seoul National University Hospital
Collaborating Sponsors:
National Rehabilitation Center, Seoul, Korea
Conditions:
Traumatic Brain Injury
Attention Deficit
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Traumatic brain injury (TBI) is an important global health concern. Recently, advances in neurocritical care have led to an increase in the number of recovering TBI patients, and concomittantly in the...
Detailed Description
Traumatic brain injury (TBI) is an important global health concern. It is estimated that about 70 million individuals will suffer a traumatic brain injury (TBI) each year. Serious TBIs for hospitaliza...
Eligibility Criteria
Inclusion
- 19 years or older
- At least 6 months since traumatic brain injury
- Cognitive disability measured by:
- A) K-MoCA score 25 or below, or B) Trail making test A \> 50.25s or B \> 142.53s
Exclusion
- Infection, open wound, bleeding, skull defect, or metal plates at or near tDCS site
- history of seizure
- Language disorder
- Serious cognitive deficit with K-MoCA score below 10
- Pregnancy or possibility of pregnancy
- MRI contraindications
- Previous medical history that may affect the patient's cognitive abilities (i.e. previous stroke, hypoxic ischemic encephalopathy, schizophrenia)
- Change in dosage of the following medications within the previous 2 weeks
- rivastigmine
- donepezil
- memantine
- antiepiletic medications
Key Trial Info
Start Date :
March 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 18 2023
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT05302362
Start Date
March 14 2022
End Date
August 18 2023
Last Update
April 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 110-744